Preferred Pharmaceuticals recalls

Preferred Pharmaceuticals appears in 55 official U.S. recall notices indexed by RecallRadar.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 g Tube, Generic for: Maxitrol,…
  FDA Drug · Class II · 2019-07-31 · Preferred Pharmaceuticals
  Reason: CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
• Robafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextromethorphan HBr, USP 10mg,/Guaifenesin, USP 100mg, 118mL (4oz) bottl…
  FDA Drug · Class II · 2019-06-26 · Preferred Pharmaceuticals
  Reason: CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
• Losartan Potassium Tab
  FDA Drug · Class II · 2019-05-22 · Preferred Pharmaceuticals
  Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
• Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC: 68788-0048-09), Rx Only, Mfg: Tor…
  FDA Drug · Class II · 2019-03-27 · Preferred Pharmaceuticals
  Reason: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.
• Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Su…
  FDA Drug · Class II · 2018-08-29 · Preferred Pharmaceuticals
  Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.